Park Ha Biological Technology Co., Ltd. (BYAH)
| Market Cap | 3.86M |
| Revenue (ttm) | 2.77M |
| Net Income (ttm) | -19.41M |
| Shares Out | 2.10M |
| EPS (ttm) | -37.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 84,709 |
| Open | 1.700 |
| Previous Close | 1.700 |
| Day's Range | 1.700 - 1.970 |
| 52-Week Range | 1.700 - 2,074.500 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 24, 2026 |
About BYAH
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People’s R... [Read more]
Financial Performance
In fiscal year 2024, BYAH's revenue was $2.38 million, a decrease of -3.14% compared to the previous year's $2.46 million. Earnings were $478,561, a decrease of -43.83%.
Financial StatementsNews
Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering
Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the pricing of a best-efforts follow-on public offering of 21,875,...
Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH
Wuxi, China, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH; the “Company” or “PHH”) announced that the Company will be changing its ticker symbol from “PHH” to...
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product s...
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and fran...
Park Ha Biological Aims For U.S. IPO At Sky-High Valuation
Park Ha Biological Technology Co., Ltd. seeks $6 million in an IPO, but has wildly excessive valuation expectations given its small size and fluctuating financial metrics. The company faces numerous r...
U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market
While major IPOs are on hold until after Labor Day, three small deals were completed in the last week of August. Two SPACs, GigCapital7 and Black Spade Acquisition II, raised $200 million and $150 mil...